Functioning in schizophrenia from the perspective of psychologists: A worldwide study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 26 01 2019
accepted: 21 05 2019
entrez: 7 6 2019
pubmed: 7 6 2019
medline: 12 2 2020
Statut: epublish

Résumé

Schizophrenia is a severe mental disorder associated with impairment in functioning. A multidisciplinary approach is essential to help individuals with this health condition, and psychological interventions are considered a priority. The International Classification of Functioning, Disability and Health (ICF) offers a theoretical framework for assessing functioning and disability. The ICF Core Sets for schizophrenia are a list of ICF categories describing the most common problems in functioning of persons affected by this health condition. This study aimed to explore the content validity of these ICF Core Sets and to identify the most common problems in people with schizophrenia from the perspective of psychologists. Psychologists with experience of schizophrenia treatment were recruited for a three-round Delphi study in order to gather their views regarding the problems commonly presented by these patients. A total of 175 psychologists from 46 countries covering the six WHO regions answered the first-round questionnaire, and 137 completed all three rounds. The 7,526 concepts extracted from first-round responses were linked to 412 ICF categories and 53 personal factors. Consensus (≥75% agreement) was reached for 76 ICF categories and 28 personal factors. Seventy-three of the 97 ICF categories that form the Comprehensive ICF Core Set for schizophrenia achieved consensus, and only three categories that yielded consensus do not feature in this Core Set. These results support the content validity of these ICF Core Sets from the perspective of psychologists. This provides further evidence of the suitability of the ICF framework for describing functioning and disability in persons with schizophrenia.

Identifiants

pubmed: 31170249
doi: 10.1371/journal.pone.0217936
pii: PONE-D-19-02521
pmc: PMC6553782
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0217936

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Eur Psychiatry. 2018 Aug;52:54-60
pubmed: 29730449
Schizophr Res. 2010 Sep;122(1-3):232-8
pubmed: 20347271
Ann Gen Psychiatry. 2011 Jun 24;10:18
pubmed: 21702932
Neuropsychiatr Dis Treat. 2014 Jan 28;10:167-81
pubmed: 24511232
Br J Psychiatry. 2016 Apr;208(4):316-9
pubmed: 27036696
Psychooncology. 2010 Jun;19(6):594-605
pubmed: 19655303
Schizophr Bull. 2018 Apr 6;44(3):653-661
pubmed: 29036391
Disabil Rehabil. 2019 Jul;41(14):1727-1738
pubmed: 29509044
Am J Psychiatry. 2012 Jul;169(7):710-8
pubmed: 22581070
Can J Psychiatry. 2017 Sep;62(9):617-623
pubmed: 28703017
Disabil Rehabil. 2018 Nov;40(23):2756-2766
pubmed: 28756686
J Consult Clin Psychol. 2012 Aug;80(4):674-86
pubmed: 22663901
Eur Child Adolesc Psychiatry. 2018 Nov;27(11):1459-1471
pubmed: 29520539
Schizophr Res. 2018 Nov;201:39-45
pubmed: 29709490
Psychol Res Behav Manag. 2018 Apr 10;11:123-131
pubmed: 29695941
J Psychiatr Res. 2018 Aug;103:134-141
pubmed: 29852420
Mol Neurobiol. 2018 Jun;55(6):5075-5100
pubmed: 28822116
J Rehabil Med. 2005 Jul;37(4):212-8
pubmed: 16024476
Australas Psychiatry. 2017 Dec;25(6):600-602
pubmed: 28875719
Schizophr Res. 2018 May;195:86-92
pubmed: 28867518
Schizophr Bull. 2011 Sep;37 Suppl 2:S63-70
pubmed: 21860049
Phys Ther. 2016 Aug;96(8):1262-75
pubmed: 26847005
Disabil Rehabil. 2014;36(3):177-84
pubmed: 23651126
J Psychiatr Res. 2018 Feb;97:8-15
pubmed: 29156414
J Psychiatry Neurosci. 2013 Nov;38(6):366-80
pubmed: 23527885
Mol Psychiatry. 2018 Apr;23(4):1076-1083
pubmed: 28416810
Br J Math Stat Psychol. 2004 May;57(Pt 1):1-19
pubmed: 15171798
Psychol Health. 2008;23(6):639-59
pubmed: 25160808
Expert Rev Neurother. 2017 Jul;17(7):713-723
pubmed: 28511562
J Clin Psychiatry. 2018 May/Jun;79(3):
pubmed: 29701938
Am J Phys Med Rehabil. 2011 Nov;90(11 Suppl 2):S79-96
pubmed: 21975679
Disabil Rehabil. 2019 Mar;41(5):574-583
pubmed: 26984720
Psychiatry Res. 2017 May;251:162-167
pubmed: 28208077
J Consult Clin Psychol. 2018 Jan;86(1):1-14
pubmed: 29172590
J Adv Nurs. 2000 Oct;32(4):1008-15
pubmed: 11095242
J Psychiatr Res. 2018 Jul;102:201-206
pubmed: 29689517
Schizophr Bull. 2012 Mar;38(2):209-14
pubmed: 21857009
Neuropsychol Rehabil. 2018 Apr;28(3):387-397
pubmed: 27150346
Community Ment Health J. 2017 Feb;53(2):127-133
pubmed: 27295054
Eur J Phys Rehabil Med. 2015 Feb;51(1):105-17
pubmed: 24686893
Biol Psychiatry. 2013 May 15;73(10):1015-23
pubmed: 23452665

Auteurs

Laura Nuño (L)

Clinical Institute of Neurosciences (ICN), Hospital Clinic, Barcelona, Spain.
Department of Social Psychology and Quantitative Psychology, University of Barcelona, Barcelona, Spain.

Georgina Guilera (G)

Department of Social Psychology and Quantitative Psychology, University of Barcelona, Barcelona, Spain.
Group on Measurement Invariance and Analysis of Change (GEIMAC), Institute of Neurosciences, University of Barcelona, Barcelona, Spain.

Michaela Coenen (M)

Institute for Medical Information Processing, Biometry and Epidemiology-IBE, Research Unit for Biopsychosocial Health, Ludwig-Maximilians-Universität (LMU), Munich, Germany.
Pettenkofer School of Public Health, Munich, Germany.
ICF Research Branch, a cooperation partner within the WHO Collaborating Centre for the Family of International Classifications in Germany (at DIMDI), Munich, Germany.

Emilio Rojo (E)

Hospital Benito Menni CASM, Sisters Hospitallers, Sant Boi de Llobregat, Spain.
Department of Psychiatry, International University of Catalonia, Barcelona, Spain.

Juana Gómez-Benito (J)

Department of Social Psychology and Quantitative Psychology, University of Barcelona, Barcelona, Spain.
Group on Measurement Invariance and Analysis of Change (GEIMAC), Institute of Neurosciences, University of Barcelona, Barcelona, Spain.

Maite Barrios (M)

Department of Social Psychology and Quantitative Psychology, University of Barcelona, Barcelona, Spain.
Group on Measurement Invariance and Analysis of Change (GEIMAC), Institute of Neurosciences, University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH